Acute Heart Failure Complicating Acute Coronary Syndromes A Deadly Intersection

Circulation

Volumn 109, Issue 4, 2004, Pages 440-442

  Velazquez, Eric J ^a   Pfeffer, Marc A ^b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Coronary disease; Focused Perspectives; Heart failure; Myocardial infarction

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; APOPTOSIS; CELL DEATH; CELL LOSS; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HIGH RISK PATIENT; HUMAN; INCIDENCE; LUNG CONGESTION; MEDICAL DECISION MAKING; MORTALITY; OUTCOMES RESEARCH; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; REVIEW; SIGNAL TRANSDUCTION; ST SEGMENT; STUNNED HEART MUSCLE; SURVIVAL RATE; TREATMENT PLANNING;

ACUTE DISEASE; ANGINA, UNSTABLE; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; SYNDROME;

EID: 0842307479     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000113460.23813.50     Document Type: Review

References (20)

1. Peel AAF, Semple T, Wang I, et al. A coronary prognostic index for grading the severity of infarction. Br Heart J. 1962;24:745-760.
2. Killip T, Kimball J. Treatment of myocardial infarction in a coronary care unit: a two-year experience with 250 patients. Am J Cardiol. 1967;20:457-464.
3. Norris RM, Brandt PW, Caughey DE, et al. A new coronary prognostic index. Lancet. 1969;1:274-278.
4. Solomon SD, Glynn RJ, Greaves S, et al. Recovery of ventricular function in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med. 2001;134:451-458.
5. Braunwald E, Kloner RA. The stunned myocardium: prolonged, post-ischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
6. Abbate A, Biondi-Zoccai GGL, Bussani R, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol. 2003;41:753-760.
7. Spencer F, Mayer T, Goldbert R, et al. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol. 1999;34:1378-1387.
8. Steg PG, Dabbous OH, Feldman LJ, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 2003;109:494-499.
9. Velazquez EJ, Criger DA, Hasdai D, et al. Predictors of heart failure development after non-ST elevation acute coronary syndromes. J Am Coll Cardiol. 2001;37:332A.
10. Ali A, Rybicki B, Alam M, et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J. 1999;138:1133-1139.
11. Lee K, Woodlief L, Topol E, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41 021 patients. Circulation. 1995;91:1659-1668.
12. Pfeffer M, Braunwald E, Moye L, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-676.
13. Velazquez EJ, Pfeffer MA, McMurray J, et al. VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context. Eur J Heart Fail. 2003;5:537-544.
14. O'Connor C, Hathaway W, Bates R, et al. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. Am Heart J. 1997;133:663-673.
15. Wu A, Parsons L, Every N, et al. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction. J Am Coll Cardiol. 2002;40:1389-1394.
16. Velazquez EJ, Armstrong P, Weaver WD, et al. An international perspective on heart failure and left ventricular systolic dysfunction complicating acute myocardial infarction: the VALIANT registry. J Am Coll Cardiol. 2003;41:148A.
17. Spencer F, Meyer T, Gore J, et al. Heterogeneity in the management and outcomes of patients with acuter myocardial infarction complicated by heart failure. The National Registry of Myocardial Infarction. Circulation. 2002;105:2605-2610.
18. Jacobs DR, Kroenke C, Crow RI, et al. PREDICT: a simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina. Circulation. 1999;100:599-607.
19. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385-1390.
20. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321.